DOI: https://doi.org/10.4414/smw.2020.20261
The coronavirus disease is caused by a new virus (SARS-Cov-2) of the coronavirus family. The virus was identified as a cause of pneumonia and the disease named COVID-19 on 7 January 2020. On 11 March 2020, the World Health Organization (WHO) declared COVID-19 as a pandemic [1].
Vascular and interventional radiology (IR), which offers a very wide spectrum of interventions from emergency procedures to highly specialised elective interventions, is affected by changes and adjustments in daily workflow necessary for coping with the pandemic. Given the importance of a continuum in providing services and the exigency of protecting healthcare professionals during this period, the Swiss Society of Vascular and Interventional Radiology (SSVIR) is releasing guidance for interventional radiologists as preparedness for managing COVID-19 patients, the workflow of non-COVID-19 patients and optimising interactions with other healthcare professionals. Because of the rapidly changing nature of the pandemic, these recommendations might be subject to regular updates.
In addition to guidelines from the Swiss Federal Office of Public Health (BAG-OFSP) [2], institutional local policies (defined as measures established by each institution) and international expert panel positions [3], the SSVIR recommendations are based on the following principles:
As the risk of transmission of the SARS-Cov-2 is directly related to the degree of contact with COVID-19 positive patients, protective measures are mandatory for the IR team.
Screen the patient for clinical signs suggestive of COVID-19 before entering the IR suite when possible. Any patient who cannot be questioned is considered a suspected case of COVID-19.
Develop an isolation and management plan for COVID-19 suspect patients in the IR suite.
Every patient entering the IR suite should wear a surgical mask (face mask) and follow appropriate hand hygiene procedures.
Inform patients about preventive measures to ensure patient and IR team safety.
In March 13, 2020, the OFSP stated (Ordonnance 2 COVID-19, Art. 10a) that “health institutions are prohibited from carrying out examinations, treatments and nonurgent interventions” [2] and are asked to cancel planned interventions accordingly. Defining “nonurgent interventions” might be challenging. The SSVIR considers that the decision-making process should integrate multiple factors and take into account risks and benefits for the patient in a personalised approach. However, to guide decision making, IR activities could be stratified as reported in table 2 . Priority 1 corresponds to procedures that should be performed urgently, priority 2 to those that should be done within 7 days, priority 3 to procedures to perform as soon as possible depending on availability of facilities/resources but within 30 days, and priority 4 to interventions that can be performed after 30 days. Patients who have their interventions cancelled should be contacted by a dedicated and instructed team member. Patients should be instructed to call back to a dedicated phone number if their symptoms or clinical conditions have changed.
The IR team should be able to schedule patients for interventions, in accordance with the priority, as mentioned above. Patients should be informed and instructed to call back a dedicated phone number if their symptoms or clinical conditions have to change.
Encourage virtual clinical visits or teleconsulting.
Reduce onsite IR workforces to institutional needs.
Encourage building two separate teams able to act independently, using the rotation principle, to avoid cross physical coverage.
Promote/develop distant reporting.
Halt unnecessary meetings and hold virtual meetings in preference.
Follow institutional policies on social distancing, personal protective equipment and hand hygiene.
Follow institutional policies on how to handle personnel with unprotected contact to persons or personnel with COVID-19 symptoms [5, 6].
Maintain an appropriate supply of personal protection equipment.
Optimise utilisation of materials.
Plan to maintain supplies to cover IR services, but do not overstock to preserve the global supply.
Low-supply items should be reserved for critical care.
Visitors should not be allowed to access IR facilities, including recovery facilities and day hospitals.
Inform and instruct patients.
Limit physical interactions between healthcare professionals and their colleagues.
Promote teleconferencing for supervision and remote readout, whenever applicable.
Table 2: IR intervention priority: proposal from the Swiss Society of Vascular and Interventional Radiology. | ||
---|---|---|
Definition | Interventions | |
Priority 1 | Urgent Within 24 hours |
Embolisation for acute bleeding |
TIPSS/BRTO for acute bleeding | ||
Endovascular management vascular pseudoaneurysm | ||
Endovascular management of acute aortic syndrome | ||
Endovascular management of acute ischaemia (peripheral, visceral) | ||
Catheter directed management of acute pulmonary embolism | ||
Endovascular management of acute vena cava syndrome | ||
Intravascular foreign body retrieval | ||
Temporary venous access for dialysis (acute renal failure) | ||
Biliary drainage (sepsis) | ||
Drainage of collections (sepsis) | ||
Any other intervention fulfilling the same criteria (multidisciplinary decision encouraged) | ||
Priority 2 | Short-term planning Within 7 days |
Endovascular management of high risk aortic aneurysm |
Endovascular management of critical limb ischaemia | ||
Endovascular management of superior vena cava syndrome (subacute) | ||
Endovascular management of acute deep vein thrombosis | ||
Inferior vena cava filter insertion | ||
Endovascular management of arteriovenous shunt acute dysfunction | ||
Tunnelled dialysis catheters | ||
Central venous access and PICCs | ||
Nephrostomy | ||
Airway / gastrointestinal tract stenting (obstruction) | ||
Drainage of collection | ||
Biopsies of transplanted solid organs | ||
Fluoroscopy-guided lumbar puncture | ||
Any other intervention fulfilling the same criteria (multidisciplinary decision encouraged) | ||
Priority 3 | Time sensitive intervention As soon as possible and no more than 30 days |
Endovascular management of chronic peripheral ischaemia (non claudicant) |
Endovascular visceral ischemia (subacute) | ||
Endovascular management of arteriovenous shunt dysfunction | ||
Endovascular management of superior vena cava syndrome | ||
Lymphatic thoracic duct embolisation | ||
Malignant tumour ablation/chemoembolisation/radioembolisation | ||
Portal vein embolisation | ||
Airway/gastrointestinal tract stenting (no obstruction) | ||
Gastrostomy/jejunostomy | ||
Tunnelled peritoneal/pleural catheters | ||
Needle biopsy | ||
Acute pain management | ||
Any other intervention fulfilling the same criteria (multidisciplinary decision required) | ||
Priority 4 | Acceptable to be planned after 30 days | Embolisation of peripheral/visceral arteriovenous malformation |
Management of low flow vascular malformation | ||
Endovascular management of chronic peripheral (claudicant)/visceral ischaemia | ||
Endovascular management of vascular aneurysm | ||
Endovascular management of chronic venous obstruction | ||
Management of pelvic congestion syndrome | ||
Embolisation of scrotal varicocele | ||
Management of varicose veins | ||
Portal vein recanalisation | ||
TIPSS for ascites | ||
Inferior vena cava filter retrieval | ||
Venous sampling | ||
Management of benign tumours | ||
Intervention for infertility | ||
Tube drainage change | ||
Chronic pain management intervention |
BRTO = balloon-occluded retrograde transvenous obliteration; IR = interventional radiology; PICC= peripherally inserted central catheter; TIPSS = transjugular intrahepatic portosystemic shunt
No financial support and no other potential conflict of interest relevant to this article was reported.
1World Health Organization. Coronavirus disease COVID-19 Data. https://who.imt/emergencies/disease/novel-coronavirus-2019.
2New coronavirus: measures, ordinance and explanations. https://www.bag.admin.ch/bag/fr/home/krankheiten/ausbrueche-epidemien-pandemien/aktuelle-ausbrueche-epidemien/novel-cov/massnahmen-des-bundes.html#-834045337
3Joint CIRSE-APSCVIR checklist to prepare IR departments for COVID 19. https://www.cirse.org/education/covid-19-resource-centre/
4 Swiss Society Of Intensive Care Medicine. Recommendations for the admission of patients with COVID-19 to intensive care and intermediate care units (ICUs and IMCUs). Swiss Med Wkly. 2020;150:w20227. doi:https://doi.org/.https://doi.org/10.4414/smw.2020.20227
5Management of COVID-19 positive or suspect employees involved in care of patients in acute care hospitals. https://www.swissnoso.ch
6Recommendations for healthcare workers, having had unprotected (without mask) contact with COVID-19 cases. https://www.swissnoso.ch
No financial support and no other potential conflict of interest relevant to this article was reported.